The role of phytoestrogens in the complex therapy and prevention of the recurrent lower urinary tract infection in climacteric patients

Nashivochnikova N.A., Krupin V.N., Zubova S.Yu., Leanovich V.E.

1) Privolzhsky Research Medical University, Ministry of Health of Russia, Nizhny Novgorod, Russia; 2) N.A. Semashko Nizhny Novgorod Regional Clinical Hospital, Nizhny Novgorod, Russia; 3) Akvion LLC, Moscow, Russia
Objective: To study the effect of Mense dietary supplements on the state of the urogenital zone in patients with recurrent lower urinary tract infection during peri- and postmenopause and to evaluate the risk of recurrent urinary tract infection.
Materials and methods: The study included 86 patients in peri– and postmenopause with the symptoms of vaginal and cystourethral atrophy and recurrent cystitis. The main group consisted of 44 patients, the control group included 42 patients. The patients of both groups received standard therapy for acute urinary infection. To prevent recurrent cystitis, all patients were administered medications containing cranberry proanthocyanidins. The patients were also recommended to consume not less than 1.5L of fluid per day and to maintain the proper hygiene of the urinary tract. The patients of the main group additionally received Mense dietary supplements, 1 or 2 capsules per day during a meal for one month. The state of pelvic venous hemodynamics and microcirculation of the bladder wall were assessed with the help of Doppler sonography and laser Doppler flowmetry. Bladder microcirculation parameters were measured using laser analyser of blood microcirculation (LAKK-02, Russia).
Results: During the study all the patients of the main group noticed the considerable improvement in general well-being, decrease in tenderness, relief of pain in the lower abdomen and discomfort in the urethra area after 1 and 6 months. The use of Mense dietary supplements in women with chronic recurrent cystitis in the period of peri– and postmenopause helps to achieve higher clinical effect due to the remarkable improvement in the circulation of the bladder wall and urethra and positive dynamics in pelvic venous blood flow.
Conclusion: The complex therapy containing Mense supplements with phytoestrogens for the recurrent infection of the urinary tract during peri– and postmenopause contributes to the improvement in the state of the urogenital zone, and also considerably reduces the number of cystitis recurrences.

Authors' contributions: Nashivochnikova N.A. – development of the study design, obtaining data for analysis, review of publications on the topic of the article, analysis of the data obtained, writing the text of the manuscript; Leanovich V.E. – review of publications on the topic of the article, writing the text of the manuscript; Krupin V.N. – data collection, analysis of the data obtained; Zubova S.Yu. – data acquisition for analysis.
Conflicts of interest: The authors declare no possible conflicts of interest.
Funding: The article was financially supported by the Akvion Company, Russia.
Ethical Approval: The study was approved by the Ethical Review Board of the Privolzhsky Research Medical University, Ministry of Health of Russia.
Patient Consent for Publication: All patients signed an informed consent for the publication of their data.
Authors' Data Sharing Statement: The data supporting the findings of this study are available on request from the corresponding author after approval from the principal investigator.
For citation: Nashivochnikova N.A., Krupin V.N., Zubova S.Yu., Leanovich V.E. The role of phytoestrogens
in the complex therapy and prevention of the recurrent lower urinary tract infection in climacteric patients.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2023; (8): 141-152 (in Russian)
https://dx.doi.org/10.18565/aig.2023.165

Keywords

climacteric
phytoestrogens
complex therapy
prevention
recurrent cystitis

References

  1. Ozer K., Horsanali M.O., Gorgel S.N., Horsanali B.O., Ozbek E. Association between benign prostatic hyperplasia and neutrophil-lymphocyte ratio, an indicator of inflammation and metabolic syndrome. Urol. Int. 2017; 98: 466-71. https://dx.doi.org/10.1159/000448289.
  2. Раснер П.И., Пушкарь Д.Ю. Симптомы нижних мочевых путей: медикаментозное лечение симптомов фазы накопления (клиническая лекция). Consilium Medicum. 2016; 18(7): 30-6. [Rasner P.I., Pushkar D.Yu. Lower urinary tract symptoms: drug treatment accumulation phase symptoms (clinical lecture). Consilium Medicum. 2016; 18(7): 30-6. (in Russian)].https://dx.doi.org/10.26442/2075-1753_2016.7.30-36.
  3. Трухан Д.И., Юренев Г.Л., Макушин Д.Г., Чусова Н.А. Симптомы нижних мочевых путей: дифференциальный диагноз на этапе оказания первичной медико-санитарной помощи. Справочник поликлинического врача. 2019; 3: 23-28. [Trukhan D.I., Yurenev G.L., Makushin D.G., Chusova N.A. Lower urinary tract symptoms: differential diagnosis at the primary health care stage. Directory of the Polyclinic Doctor. 2019; (3): 23-8. (in Russian)].
  4. Зайцев А.В., Перепанова Т.С., Гвоздев М.Ю., Арефьева О.А. Инфекции мочевыводящих путей. ч.1. М.; 2017. [Zaytsev A.V., Perepanova T.S., Gvozdev M.Yu., Arefieva O.A. Urinary tract infections. Part 1. Moscow; 2017. (in Russian)].
  5. Зайцев А.В., Ширяев А.А., Ким Ю.А., Сазонова Н.А., Прилепская Е.А., Васильев А.О., Пушкарь Д.Ю. Инфекции мочевыводящих путей. Современная тактика врача-уролога. РМЖ. 2019; 11: 21-6. [Zaytsev A.V., Shiryaev A.A., Kim Yu.A. et al. Urinary tract infections: current management strategy. RMJ. 2019; (11): 21-6. (in Russian)].
  6. Российское общество урологов. Цистит у женщин. Клинические рекомендации. 2021. [Russian Society of Urologists. Cystitis in women. Clinical guidelines. 2021. (in Russian)].
  7. Flores-Mireles A.L., Walker J.N., Caparon M., Hultgren S.J. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat. Rev. Microbiol. 2015; 13(5): 269-84. https://dx.doi.org/10.1038/nrmicro3432.
  8. Ковалев Г.В., Шкарупа Д.Д., Зайцева А.О., Старосельцева O.Ю., Бородулина И.В., Калинина Д.С., Мусиенко П.Е. Особенности клеточной регуляции нижних мочевыводящих путей как причина гиперактивности мочевого пузыря и снижения эффективности медикаментозной терапии. Урология. 2020; 5: 149-56. [Kovalev G.V., Shkarupa D.D., Zaytseva A.O., Staroseltseva O.Yu., Borodulina I.V., Kalinina D.S., Musienko P.E. Cellular regulation of the lower urinary tract as a cause of the bladder overactivity and reduced efficiency of pharmacotherapy. Urology. 2020; (5): 149-56.(in Russian)]. https://dx.doi.org/10.18565/urology.2020.5.149-156.
  9. Nomiya M., Sagawa K., Yazaki J., Takahashi N., Kushida N., Haga N. et al. Increased bladder activity is associated with elevated oxidative stress markers and proinflammatory cytokines in a rat model of atherosclerosis-induced chronic bladder ischemia. Neurourol. Urodyn. 2012; 31(1): 185-9.https://dx.doi.org/10.1002/nau.21191.
  10. Mansfield K.J., Chen Z., Moore K.H., Grundy L. Urinary tract infection in overactive bladder: an update on pathophysiological mechanisms. Front. Physiol. 2022; 13: 886782. https://dx.doi.org/10.3389/fphys.2022.886782.
  11. Montalbetti N., Rued A.C., Clayton D.R., Ruiz W.G., Bastacky S.I., Prakasam H.S. et al. Increased urothelial paracellular transport promotes cystitis. Am. J. Physiol. Renal Physiol. 2015; 309(12): F1070-81.https://dx.doi.org/10.1152/ajprenal.00200.2015.
  12. Перепанова Т.С., Хазан П.Л., Казаченко А.В., Малова Ю.А. Внутрипузырное восполнение гликозаминогликанов при ведении пациентов с циститами. Экспериментальная и клиническая урология. 2019; 3: 110-7. [Perepanova T.S., Khazan P.L., Kazachenko A.V., Malova Yu.A. Intravesical replacement of glycosaminoglycans in patient management with cystitis. Experimental and Clinical Urology. 2019; (3): 110-7. (in Russian)].https://dx.doi.org/10.29188/2222-8543-2019-11-3-110-117.
  13. Ермакова Е.И., Балан В.Е., Тихомирова Е.В., Лазарева И.Н., Лапина А.В., Панина Е.М. Генитоуринарный менопаузальный синдром: диагностика и принципы лечения (краткие клинические рекомендации). Российский вестник акушера-гинеколога. 2017; 17(6): 89 95. [Ermakova E.I., Balan V.E., Tikhomirova E.V., Lazareva I.N., Lapina A.V., Panina E.M. Genitourinary syndrome of menopause: diagnosis and principles of treatment (brief clinical recommendations). Russian Bulletin of Obstetrician-Gynecologist. 2017; 17(6): 89 95. (in Russian)]. https://dx.doi.org/10.17116/rosakush201717689-95.
  14. Балан В.Е., Амирова Ж.С., Ковалёва Л.А., Краснопольская И.В., Ермакова Е.И. Особенности терапии нарушений мочеиспускания у женщин в климактерии. Российский вестник акушера-гинеколога. 2015; 15(3): 29 34. [Balan V.E., Amirova Zh.S., Kovalev L.A., Krasnopol'skaia I.V., Ermakova E.I. Specific features of therapy for disordered urination in menopausal women. Russian Bulletin of Obstetrician-Gynecologist. 2015; 15(3): 29 34. (in Russian)]. https://dx.doi.org/10.17116/rosakush201515329-34.
  15. Мозес В.Г., Ушакова Г.А. Варикозное расширение вен малого таза у женщин в основные возрастно-биологические периоды жизни. Клиника, диагностика, лечение, профилактика. М.: Эликс Ком; 2006. 104с. [Moses V.G., Ushakova G.A. Varicose veins of the pelvis in women during the main age-biological periods of life. Clinic, diagnosis, treatment, prevention. Moscow: Elix Kom; 2006. 104p. (in Russian)].
  16. Ющенко А.Н. Варикозная болезнь малого таза: казуистика или распространенная болезнь? Новости медицины и фармации. 2005; 9(169): 14-6. [Yushchenko A.N. Varicose pelvic disease: casuistry or a common disease? Medical and Pharmacy News. 2005; 9(169): 14-6. (in Russian)].
  17. Тапильская Н.И., Миронова А.В., Силаева Е.А., Шкарупа А.В., Глушаков Р.И. Синдром хронической тазовой боли у женщин: факторы риска, алгоритмы дифференциальной диагностики, лечения и профилактики. Проблемы репродукции. 2021; 27(2): 56 64. [Tapil’skaya N.I., Mironova A.V., Silaeva E.A., Shkarupa A.V., Glushakov R.I. Chronic pelvic pain syndrome in women: risk factors, differential diagnosis, treatment and prevention. Russian Journal of Human Reproduction. 2021; 27(2): 56 64. (in Russian)].https://dx.doi.org/10.17116/repro20212702156.
  18. Зайцев А.В., Шаров М.Н., Арефьева О.А., Пушкарь Д.Ю. Синдром болезненного мочевого пузыря/интерстициальный цистит: факторы прогноза клинического течения заболевания. Вестник урологии. 2018; 6(3): 26-35. [Zaitsev A.V., Sharov M.N., Arefieva O.A., Pushkar D.Yu. Interstitial cystitis / bladder pain syndrome: factors predicting the clinical course of the disease. Bulletin of Urology. 2018; 6(3): 26-35. (in Russian)].https://dx.doi.org/10.21886/2308-6424-2017-6-3-26-35.
  19. Балан В.Е., Ковалева Л.А. Комплексное лечение урогенитальной атрофии и рецидивирующих инфекций мочевых путей в постменопаузе. Эффективная фармакотерапия. Акушерство и гинекология. 2013; 18: 48-53. [Balan V.Ye., Kovalyova L.A. Combination treatment of urogenital atrophy and recurrent urinary tract infections in postmenopausal women. Effective Pharmacotherapy. Obstetrics and Gynecology. 2013; (18): 48-53.(in Russian)].
  20. Шарипова К.К., Гатин Р.Ф., Айдарбекова А.С., Сулейменов К.Г. Расстройства мочеиспускания у женщин в климактерии. Вестник АГИУВ. 2018; 1: 47-52. [Sharipova K.K., Gatin R.F., Aydarbekova A.S., Suleimenov K.G. Urination disorders in women in climacteria. AGIUV Bulletin. 2018; (1): 47-52. (in Russian)].
  21. Доброхотова Ю.Э., Ильина И.Ю., Венедиктова М.Г., Уткина М.С., Морозова К.В., Суворова В.А. Лечение генитоуринарного синдромау онкогинекологических пациенток. РМЖ; 2017; 26: 1921-5. [Dobrokhotova Yu.E., Ilyina I.Yu., Venediktova M.G., Utkina M.S., Morozova K.V., Suvorova V.A. Treatment of genitourinary menopausal syndrome in patients with gynecologic cancer. RMJ. 2017; (26): 1921-5. (in Russian)].
  22. Wuttke W., Seidlová-Wuttke D., Gorkow C. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas 2003; 44(Suppl. 1) S67-77. https://dx.doi.org/10.1016/s0378-5122(02)00350-x.
  23. Зайдиева Я.З. Альтернативная терапия менопаузальных расстройств у женщин в климактерии. РМЖ. 2017; 12: 873-8. [Zaydieva Y.Z. Alternative therapy of menopausal disorders in women of climacterical age (literature review). RMJ. 2017; (12): 873-8. (in Russian)].
  24. Ших Е.В., Гребенщикова Л.Ю. Рациональная дотация микронутриентов как способ повышения качества жизни у пациенток с климактерическим синдромом. Медицинский совет. 2017; 13: 166-71. [Shikh E.V., Grebenshhikova L.Y. A rational grant of micronutrients as a way to improve quality of life of climacteric syndrome patients. Medical Council. 2017; (13): 166-71. (in Russian)]. https://dx.doi.org/10.21518/2079-701X-2017-13-166-171.
  25. Перепанова Т.С., Козлов Р.С., Локшин К.Л. и др. Антимикробная терапия и профилактика инфекций почек, мочевыводящих путей и мужских половых органов. Федеральные клинические рекомендации. М.; 2021. [Perepanova T.S., Kozlov R.S., Lokshin K.L. et al. Antimicrobial therapy and prevention of kidney, urinary tract and male genital infections. Federal clinical guidelines. Moscow; 2021. (in Russian)].
  26. Bonkat G., Bartoletti R., Bruyère F., Cai T., Geerlings S.E., Köves B. et al. EAU guidelines on urological infections. European Association of Urology; 2023.
  27. Нашивочникова Н.А. Осознанный подход к выбору консервативной терапии ДГПЖ. РМЖ. Медицинское обозрение. 2022; 6(4): 187-94. [Nashivochnikova N.A. Informed method of choice concerning conservative therapy of BPH. Russian Medical Inquiry. 2022; 6(4): 187-94. (in Russian)]. https://dx.doi.org/10.32364/2587-6821-2022-6-4-187-194.
  28. Азизов Г.А., Козлов В.И. Модуляция кровотока в системе микроциркуляции и ее расстройство при хронической венозной недостаточности. Лазерная медицина. 2003; 3: 55-60. [Azizov G.A., Kozlov V.I. Modulation of blood flow in the microcirculation system and its disorder in chronic venous insufficiency. Laser Medicine. 2003; (3): 55-60. (in Russian)].
  29. Козлов В.И., Азизов Г.А., Гурова О.А., Литвин Ф.Ф. ЛДФ в оценке состояния и расстройств микроциркуляции крови. М.; 2012. [Kozlov V.I., Azizov G.A., Gurova O.A., Litvin F.F. LDF in assessing the condition and disorders of blood microcirculation. Moscow; 2012. (in Russian)].
  30. Нашивочникова Н.А., Крупин В.Н., Зубова С.Ю., Леанович В.Е. Комплексная прегравидарная подготовка пациенток с хроническим рецидивирующим циститом на фоне варикозного расширения вен малого таза. РМЖ. Мать и дитя. 2022; 5(1): 11-7. [Nashivochnikova N.A., Krupin V.N., Zubova S.Yu., Leanovich V.E. Complex preparation for pregnancy of women with chronic recurrent cystitis and pelvic congestion syndrome. Russian Journal of Woman and Child Health. 2022; 5(1): 11-7. (in Russian)].https://dx.doi.org/10.32364/2618-8430-2022-5-1-11-17.
  31. Шавловская О.А., Бокова И.А. Эффективность витаминов группы В при разных нозологических формах. Эффективная фармакотерапия. 2023; 19(1): 40-7. [Shavlovskaya O.A., Bokova I.A. Vitamins B effectiveness in different nosological forms. Effective Pharmacotherapy. 2023; 19(1): 40-7. (in Russian)]. https://dx.doi.org/10.33978/2307-3586-2023-19-1-40-47.
  32. Медведев М.В. Неинфекционные вагиниты – проблема 21 века. Здоровье женщины. 2016; 1: 45-8. [Medvediev M.V. Non-infectious vaginitis – a problem of the 21st century. Health of Woman. 2016; (1): 45-8.(in Russian)].
  33. Неймарк А.И., Шелковникова Н.В., Непомнящих Л.М., Давыдов А.В. Особенности хронического цистита, осложненного синдромом тазовой боли у женщин с варикозным расширением вен малого таза. Экспериментальная и клиническая урология. 2014; 4: 101-4. [Neymark A.I., Shelkovnikova N.V., Nepomnyashih L.M., Davidov A.V. The peculiarities of chronic cystitis complicated with pelvic pain syndrome in women with varicose disease of the pelvic veins. Experimental and Clinical Urology. 2014; (4): 101-4. (in Russian)].
  34. Гус А.И., Семендяев А.А., Ступин Д.А., Черепанова М.А., Бачурина С.М., Селецкий А.Н., Колесникова Л.И. Профилактика рецидива варикозной болезни вен малого таза у женщин. Акушерство и гинекология. 2016; 10: 103-8. [Gus A.I., Semendyaev A.A., Stupin D.A., Cherepanova M.A., Bachurina S.M., Seletsky A.N., Kolesnikova L.I. Prevention of recurrent varicose veins of the small pelvis in women. Obstetrics and Gynecology. 2016; (10): 103-8. (in Russian)]. https://dx.doi.org/10.18565/aig.2016.10.103-8.
  35. Ших Е.В., Махова А.А. Роль аскорбиновой кислоты и токоферола в профилактике и лечении заболеваний с точки зрения доказательной медицины. Терапевтический архив. 2015; 87(4): 98 102. [Shikh E.V, Makhova A.A. Role of ascorbic acid and tocopherol in the prevention and treatment of diseases from the standpoint of evidence-based medicine. Terapevticheskii Arkhiv.2015; 87(4): 98 102. (in Russian)]. https://dx.doi.org/10.17116/terarkh201587498-102.
  36. Тимирханова Г.А., Абдуллина Г.М., Кулагина И.Г. Витамин С: классические представления и новые факты о механизмах биологического действия. Вятский медицинский вестник. 2007; 4: 158-61. [Timirkhanova G.A., Abdullina G.M., Kulagina I.G. Vitamin C: classical ideas and new facts about the mechanisms of biological action. Vyatka Medical Bulletin. 2007;( 4): 158-61. (in Russian)].
  37. Bendek B., Afuape N., Banks E., Desai N.A. Comprehensive review of pelvic congestion syndrome: Causes, symptoms, treatment options. Curr. Opin. Obstet. Gynecol. 2020; 32(4): 237-42. https://dx.doi.org/10.1097/GCO.0000000000000637.
  38. Екимов М.В. Типология и клинические проявления оргазмических дисфункций. Сексология и сексопатология. 2003; 10: 2-11. [Yekimov M.V. Typology and clinical manifestations of orgasmic dysfunctions. Sexology and Sexopathology. 2003; (10): 2-11. (in Russian)].
  39. Vitale S.G., Caruso S., Rapisarda A.M.C., Cianci S., Cianci A. Isoflavones, calcium, vitamin D and inulin improve quality of life, sexual function, body composition and metabolic parameters in menopausal women: result from a prospective, randomized, placebo-controlled, parallel-group study. Prz Menopauzalny. 2018; 17(1): 32-8. https://dx.doi.org/10.5114/pm.2018.73791.

Received 29.06.2023

Accepted 18.08.2023

About the Authors

Natalya A. Nashivochnikova, PhD, Associate Professor at the Department of Urology named after E.V. Shakhov, Privolzhsky Research Medical University, Ministry of Health
of Russia, +79616354956, dom17.doctor@mail.ru, https://orcid.org/0000-0002-1138-1174, 603950, Russia, Nizhny Novgorod, Minin and Pozharsky sqr., 10/1.
Valentin N. Krupin, Dr. Med. Sci., Professor, Head of the Department of Urology named after. E.V. Shakhov, Privolzhsky Research Medical University,
Ministry of Health of Russia, https://orcid.org/0000-0002-4887-4888, 603950, Russia, Nizhny Novgorod, pl. Minin and Pozharsky sqr., 10/1.
Svetlana Yu. Zubova, doctor of ultrasound diagnostics, N.A. Semashko Nizhny Novgorod Regional Clinical Hospital, https://orcid.org/0000-0002-9934-3868, 603950, Russia, Nizhny Novgorod, Rodionova str., 190.
Victoria E. Leanovich, Medical director, Akvion LLC, leanovichVE@akvion.ru, https://orcid.org/0000-0001-7653-797Х, 123112, Russia, Moscow, Presnenskaya nab., 8, build.1.
Corresponding author: Natalya A. Nashivochnikova, dom17.doctor@mail.ru

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.